Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (50.0%)
Phase 41 (50.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completed

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Amiloride vs Triamterene

NCT05125237
unknownphase_4

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

NCT02522650
completedphase_3

Diuretics, Hypertension, and Arrhythmias Clinical Trial

NCT00000525

Clinical Trials (3)

Showing 3 of 3 trials
NCT05125237

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Amiloride vs Triamterene

Completed
NCT02522650Phase 4

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

Unknown
NCT00000525Phase 3

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3